TokenPost topic
Gene Therapy
6 TokenPost stories are tagged Gene Therapy. The newest appear first.
Latest Gene Therapy stories
- Ocugen Agrees to Sell OCU400 Rights in Australia, New Zealand and the ASEAN Region
The agreement would give Australian biopharma Celairis Therapeutics exclusive commercialization rights to the gene therapy candidate in those areas.
· Business
- uniQure Says FDA Grants Priority Review to Huntington’s Gene Therapy
The application seeks accelerated approval, and the company plans to begin U.S. screening for a 200-patient confirmatory trial by the end of 2026.
· Regulation
- Exin CEO Says Three AI Models Directed Gene Therapy Injections in Mice
The models received 19 candidate vectors and chose different brain regions. Seizure outcomes have not been reported.
· Technology
- Ultragenyx Pharmaceutical Inc. Agrees to Sell Fayuvi Voucher for $203 Million
The priority review voucher was received in connection with Fayuvi’s approval in September. The therapy is also known as rebisufligene etisparvovec.
· Business
- Goldman Sachs Upgrades Rocket Pharmaceuticals to Neutral on Danon Disease Therapy
The bank raised its rating from Sell after updates on RP-A501, Rocket Pharmaceuticals’ experimental treatment for the rare disorder Danon disease.
· Investing
- JPMorgan Initiates Neurogene Coverage With $60 Price Target
The overweight rating implies 132% upside from the Oct. 7 close. Neurogene shares have fallen about 32% over the past three months.
· Investing